mRNA-A 20 Year Voyage to Patients
Summary: The existence of messenger(m) RNA was hypothesized early in the days of DNA breakthroughs in the 1960s, and research from the 1990s started to reveal its potential as a therapeutic tool.
mRNA became a household name in 2020 and 2021 as arguably the most important global breakthrough of recent years, with its ability to create a specific protein underpinning vaccine development in response to Covid-19.
On December 13, 2021, EuropaBio hosted the final event of its 25th Anniversary programme with a focus on the story of mRNA. Its first steps into commercial development, challenges to bring a vaccine to millions of people and life beyond Covid – the destination for mRNA in oncology and other significant health applications.